Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ABRAHAM S SALACATA

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1255440095
CMS profile
101995
Location
ALPENA, MI

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$2,156.96

21 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

Nature of paymentAmountRecords
Travel and Lodging $1,677.57 5
Food and Beverage $479.39 16

By paying entity

PY2025 · entire year · sorted by reported total

Page 1 of 1; records 1–21 of 21 matching records. This page contains 21 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ABRAHAM S SALACATA

NPI 1255440095 · CMS profile ID 101995

Allopathic & Osteopathic Physicians / Internal Medicine / Cardiovascular Disease

ALPENA, MI

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–21 of 21 matching records. This page contains 21 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1255440095?year=2025&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ABRAHAM S SALACATA, NPI 1255440095, CMS profile ID 101995. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–21 of 21 matching records. This page contains 21 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1255440095?year=2025&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). ABRAHAM S SALACATA, NPI 1255440095, CMS profile ID 101995. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–21 of 21 matching records. This page contains 21 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1255440095?year=2025&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
ABRAHAM S SALACATA, NPI 1255440095, CMS profile ID 101995, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–21 of 21 matching records. This page contains 21 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1255440095?year=2025&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

21 matching records · $2,156.96 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 21 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–21 of 21.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Boston Scientific Corporation $13.7011/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1181193114 CMS
E.R. Squibb & Sons, L.L.C. $13.6408/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184918898 CMS
ABIOMED $101.5207/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174674531 CMS
Abbott Laboratories $22.7706/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240784971 CMS
Abbott Laboratories $35.5406/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240785127 CMS
Abbott Laboratories $14.6206/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240785597 CMS
Abbott Laboratories $71.0906/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240785689 CMS
Abbott Laboratories $53.0106/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240785785 CMS
Abbott Laboratories $813.2506/27/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1241089319 CMS
Abbott Laboratories $146.0206/27/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1241089455 CMS
Abbott Laboratories $47.3906/27/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1241089479 CMS
Abbott Laboratories $9.0206/27/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1241094600 CMS
Abbott Laboratories $7.6506/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240784441 CMS
Actelion Pharmaceuticals US, Inc. $56.8106/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174238122 CMS
E.R. Squibb & Sons, L.L.C. $14.1205/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184918892 CMS
Novartis Pharmaceuticals Corporation $15.3205/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200500439 CMS
Abbott Laboratories $11.4904/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240782239 CMS
E.R. Squibb & Sons, L.L.C. $18.7403/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184918880 CMS
Medtronic, Inc. $661.8902/25/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1219990757 CMS
Abbott Laboratories $12.4202/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240800805 CMS
Actelion Pharmaceuticals US, Inc. $16.9501/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174238127 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,254.35 23
PY2020 $1,854.77 27
PY2021 $993.92 38
PY2022 $880.13 46
PY2023 $854.49 36
PY2024 $347.73 18
PY2025 $2,156.96 21

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2021 Principal investigator $34,407.43 44
PY2020 Principal investigator $48,633.68 82
PY2019 Principal investigator $95,505.89 140

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

82 records in PY2020

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $2,541.44 12/31/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 750753903
Principal investigator 1 Amgen Inc. $3,300.00 12/24/2020 Non-covered Recipient Entity
ENDEAVOR MEDICAL RESEARCH
(GOULD): a Registry of High Cardiovascular Risk Subjects in the United States No dispute reported 06/30/2026 753887967
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $2,541.44 11/30/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 750753901
Principal investigator 1 Boehringer Ingelheim International GmbH $831.00 11/10/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899829
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $508.29 10/31/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 750753899
Principal investigator 1 Boehringer Ingelheim International GmbH $24.92 10/02/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899911
Principal investigator 1 Boehringer Ingelheim International GmbH $21.77 10/02/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899913
Principal investigator 1 Boehringer Ingelheim International GmbH $32.66 10/02/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899915
Principal investigator 1 Boehringer Ingelheim International GmbH $21.77 10/02/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899917
Principal investigator 1 Boehringer Ingelheim International GmbH $65.32 10/02/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899919
Principal investigator 1 Boehringer Ingelheim International GmbH $21.77 10/02/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899921
Principal investigator 1 Boehringer Ingelheim International GmbH $43.55 10/02/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899923
Principal investigator 1 Boehringer Ingelheim International GmbH $63.42 10/02/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899925
Principal investigator 1 Boehringer Ingelheim International GmbH $21.77 10/02/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899927
Principal investigator 1 Boehringer Ingelheim International GmbH $81.00 09/24/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899843
Principal investigator 1 Boehringer Ingelheim International GmbH $796.00 09/24/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899845
Principal investigator 1 Boehringer Ingelheim International GmbH $336.00 09/17/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749899847
Principal investigator 1 Boehringer Ingelheim International GmbH $1,591.80 09/17/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749899849
Principal investigator 1 Boehringer Ingelheim International GmbH $81.00 09/10/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899841
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $4,066.31 08/31/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 750753897
Principal investigator 1 Boehringer Ingelheim International GmbH $506.00 08/13/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749899853
Principal investigator 1 Boehringer Ingelheim International GmbH $786.00 08/13/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749899855
Principal investigator 1 Boehringer Ingelheim International GmbH $842.00 08/13/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749899859
Principal investigator 1 Boehringer Ingelheim International GmbH $504.00 08/13/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749899861
Principal investigator 1 Boehringer Ingelheim International GmbH $153.00 08/13/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749899873
Principal investigator 1 Boehringer Ingelheim International GmbH $81.00 08/07/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899851
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $2,033.16 07/31/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 750753895
Principal investigator 1 Boehringer Ingelheim International GmbH $545.00 07/24/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749899857
Principal investigator 1 Boehringer Ingelheim International GmbH $81.00 07/07/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899863
Principal investigator 1 Boehringer Ingelheim International GmbH $55.62 07/03/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899831
Principal investigator 1 Boehringer Ingelheim International GmbH $18.54 07/03/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899833
Principal investigator 1 Boehringer Ingelheim International GmbH $55.62 07/03/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899835
Principal investigator 1 Boehringer Ingelheim International GmbH $18.54 07/03/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899837
Principal investigator 1 Boehringer Ingelheim International GmbH $18.54 07/03/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899839
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $2,541.44 06/30/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 750753891
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $2,541.44 06/30/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 750753893
Principal investigator 1 Boehringer Ingelheim International GmbH $81.00 06/05/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899811
Principal investigator 1 Boehringer Ingelheim International GmbH $10.16 05/04/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899817
Principal investigator 1 Boehringer Ingelheim International GmbH $23.26 05/04/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899819
Principal investigator 1 Boehringer Ingelheim International GmbH $59.18 05/04/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899821
Principal investigator 1 Boehringer Ingelheim Pharmaceuticals, Inc. $1,749.00 05/04/2020 Non-covered Recipient Entity
ENDEAVOR MEDCL RSRCH
GLORIA AF Registry Phase II III Core No dispute reported 06/30/2026 751188499
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $508.29 04/30/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 750753889
Principal investigator 1 Boehringer Ingelheim International GmbH $693.00 04/27/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749899869
Principal investigator 1 Boehringer Ingelheim International GmbH $81.00 04/14/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899865
Principal investigator 1 Boehringer Ingelheim International GmbH $81.00 04/14/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899867
Principal investigator 1 Boehringer Ingelheim International GmbH $81.00 04/14/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899929
Principal investigator 1 Boehringer Ingelheim International GmbH $10.15 04/02/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899795
Principal investigator 1 Boehringer Ingelheim International GmbH $20.31 04/02/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899797
Principal investigator 1 Boehringer Ingelheim International GmbH $20.31 04/02/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899799
Principal investigator 1 Boehringer Ingelheim International GmbH $20.31 04/02/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899801
Principal investigator 1 Boehringer Ingelheim International GmbH $20.31 04/02/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899803
Principal investigator 1 Boehringer Ingelheim International GmbH $25.34 04/02/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899805
Principal investigator 1 Boehringer Ingelheim International GmbH $831.00 04/01/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899807
Principal investigator 1 Boehringer Ingelheim International GmbH $831.00 04/01/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899809
Principal investigator 1 Boehringer Ingelheim International GmbH $81.00 04/01/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899813
Principal investigator 1 Boehringer Ingelheim International GmbH $81.00 04/01/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899815
Principal investigator 1 Boehringer Ingelheim International GmbH $796.00 04/01/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899823
Principal investigator 1 Boehringer Ingelheim International GmbH $831.00 04/01/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899825
Principal investigator 1 Boehringer Ingelheim International GmbH $858.00 04/01/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899827
Principal investigator 1 Boehringer Ingelheim International GmbH $956.00 04/01/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749899871
Principal investigator 1 Novartis Pharmaceuticals Corporation $4,160.00 03/18/2020 Non-covered Recipient Entity
ENDEAVOR MEDICAL RESEARCH
OBSERVATIONAL REGISTRY OF TREATMENT PATTERNS IN US HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION No dispute reported 06/30/2026 721491501
Principal investigator 1 Boehringer Ingelheim International GmbH $81.00 03/11/2020 Non-covered Recipient Entity
ENDEAVOR MEDCL RSRCH
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899887
Principal investigator 1 Boehringer Ingelheim International GmbH $81.00 02/25/2020 Non-covered Recipient Entity
ENDEAVOR MEDCL RSRCH
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749899877
Principal investigator 1 Boehringer Ingelheim International GmbH $684.50 02/25/2020 Non-covered Recipient Entity
ENDEAVOR MEDCL RSRCH
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749899889
Principal investigator 1 Boehringer Ingelheim International GmbH $796.00 02/25/2020 Non-covered Recipient Entity
ENDEAVOR MEDCL RSRCH
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749899891
Principal investigator 1 Amgen Inc. $1,425.00 02/21/2020 Non-covered Recipient Entity
ENDEAVOR MEDICAL RESEARCH
(GOULD): a Registry of High Cardiovascular Risk Subjects in the United States No dispute reported 06/30/2026 731634239
Principal investigator 1 Boehringer Ingelheim International GmbH $81.00 02/12/2020 Non-covered Recipient Entity
ENDEAVOR MEDCL RSRCH
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899879
Principal investigator 1 Boehringer Ingelheim International GmbH $81.00 02/12/2020 Non-covered Recipient Entity
ENDEAVOR MEDCL RSRCH
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899881
Principal investigator 1 Boehringer Ingelheim International GmbH $336.00 02/12/2020 Non-covered Recipient Entity
ENDEAVOR MEDCL RSRCH
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899883
Principal investigator 1 Boehringer Ingelheim International GmbH $413.40 02/12/2020 Non-covered Recipient Entity
ENDEAVOR MEDCL RSRCH
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899885
Principal investigator 1 Boehringer Ingelheim International GmbH $10.24 02/05/2020 Non-covered Recipient Entity
ENDEAVOR MEDCL RSRCH
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749899893
Principal investigator 1 Boehringer Ingelheim International GmbH $20.48 02/05/2020 Non-covered Recipient Entity
ENDEAVOR MEDCL RSRCH
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749899895
Principal investigator 1 Boehringer Ingelheim International GmbH $20.48 02/05/2020 Non-covered Recipient Entity
ENDEAVOR MEDCL RSRCH
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749899897
Principal investigator 1 Boehringer Ingelheim International GmbH $20.48 02/05/2020 Non-covered Recipient Entity
ENDEAVOR MEDCL RSRCH
Empagliflozin and Heart failure (HFrEF) No dispute reported 06/30/2026 749899899
Principal investigator 1 Boehringer Ingelheim International GmbH $24.22 02/05/2020 Non-covered Recipient Entity
ENDEAVOR MEDCL RSRCH
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899901
Principal investigator 1 Boehringer Ingelheim International GmbH $20.48 02/05/2020 Non-covered Recipient Entity
ENDEAVOR MEDCL RSRCH
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899903
Principal investigator 1 Boehringer Ingelheim International GmbH $20.48 02/05/2020 Non-covered Recipient Entity
ENDEAVOR MEDCL RSRCH
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899905
Principal investigator 1 Boehringer Ingelheim International GmbH $30.72 02/05/2020 Non-covered Recipient Entity
ENDEAVOR MEDCL RSRCH
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899907
Principal investigator 1 Boehringer Ingelheim International GmbH $30.72 02/05/2020 Non-covered Recipient Entity
ENDEAVOR MEDCL RSRCH
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899909
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $3,049.73 01/31/2020 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 750753887
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $645.00 01/03/2020 Non-covered Recipient Entity
Endeavor Medical Research
BAY59-7939 prevention of CV events in vascular disease No dispute reported 06/30/2026 713676563
Principal investigator 1 Boehringer Ingelheim International GmbH $81.00 01/02/2020 Non-covered Recipient Entity
ENDEAVOR MEDCL RSRCH
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 749899875